To develop a middle-down workflow for the characterization of human recombinant erythropoietin (rhEPO) glycoforms using a sheathless capillary electrophoresis (CESI) and nanoflow liquid chromatography (nLC) based separation coupled to an Orbitrap mass spectrometer.